Back to
Great Lakes Advisors, LLC
CORT
Showing 0 of 9 quarters
Position history for
Great Lakes Advisors, LLC's holdings in Corcept Therapeutics Incorporated
No. Great Lakes Advisors exited its CORT (Corcept Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 335,895 shares worth $10.9M. Great Lakes Advisors first reported CORT in Q1 2022 and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.